 [23] 
  As I noted in the Reasons for Judgment, over half of the days of the trial were taken up with evidence and argument for the remedies phase. Due to the result on the validity of the patent in question, there was no need for the Court to make any determination on the remedies or damages issues. Sanofi and Schering submit that each party should bear its own costs for this phase. Apotex argues that it should be allowed to recover such costs. 
